Low molecular weight heparin-all-trans-retinoid acid conjugate as a drug carrier for combination cancer chemotherapy of paclitaxel and all-trans-retinoid acid-Reference-Cited by-同舟云学术

Low molecular weight heparin-all-trans-retinoid acid conjugate as a drug carrier for combination cancer chemotherapy of paclitaxel and all-trans-retinoid acid

Published:2011-08 Issue:3 Volume:86 Page:1157-1166
ISSN:0144-8617
Container-title:Carbohydrate Polymers
language:en
Short-container-title:Carbohydrate Polymers

Author:

Hou Lin,Fan Ying,Yao Jing,Zhou Jianping,Li Caocao,Fang Zhengjie,Zhang Qiang

Funder

Major Project of National Science and Technology of China

National Basic Research Program of China

Publisher

Elsevier BV

Subject

Materials Chemistry,Polymers and Plastics,Organic Chemistry

Reference58 articles.

1. Chemotherapy for advanced gastric or gastroesophageal cancer: Defining the contributions of docetaxel;Ajani;Expert Opinion on Pharmacotherapy,2006

2. Randomized phase II trial of all-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer;Arrieta;Journal of Clinical Oncology,2010

3. Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents;Bae;Journal of Controlled Release,2007

4. Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25mg/m2) in acute promyelocytic leukemia;Castaigne;Blood,1993

5. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel;Ceruti;Journal of Controlled Release,2000

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer;Carbohydrate Polymers;2024-08

2. Glycolysis-non-canonical glutamine dual-metabolism regulation nanodrug enhanced the phototherapy effect for pancreatic ductal adenocarcinoma treatment;Journal of Colloid and Interface Science;2024-07

3. Harnessing the potential of de-sulfated heparin for targeted drug delivery: A three-component approach exemplified by conjugation with galactose and paclitaxel;Carbohydrate Polymers;2024-06

4. A redox-responsive delivery system for paclitaxel based on heparin—pluronic F127 nanogel;Journal of Nanoparticle Research;2023-09

5. Development of carrier-free nanodrugs based on low molecular weight heparin–doxorubicin conjugate assembly with smart pH-triggered drug release characteristics for combinatorial antitumor therapy;New Journal of Chemistry;2022